Skip to content
ChickenStockChickenStock
Research039200
Oscotec logo

Oscotec (039200) stock

KOSDAQ · Pharmaceuticals

KRW 34,850-2.65%(-950)

As of Nov 16, 2:33 PM KST

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

17.40x

P/B

6.77x

P/S

9.40x

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
Q3 2026Consolidated · Filed Nov 13, 2026KRW 6.6 billion-KRW 6.7 billion-KRW 19.7 billion-26.6%
Q2 2026Consolidated · Filed Aug 14, 2026KRW 52.6 billionKRW 38.7 billionKRW 40.8 billion+425.6%
Q1 2026Consolidated · Filed May 14, 2026KRW 3.6 billion-KRW 10 billion-KRW 5 billion+88.4%
Q4 2025Consolidated · Filed Mar 19, 2026KRW 78.9 billionKRW 61.4 billionKRW 64 billion—
Q3 2025Consolidated · Filed Nov 12, 2025KRW 8.9 billion-KRW 400 millionKRW 600 million-69.2%
Q2 2025Consolidated · Filed Aug 14, 2025KRW 10 billion-KRW 600 million-KRW 2.5 billion+544.7%
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Consolidated · Filed Mar 19, 2026KRW 99.8 billionKRW 52.1 billionKRW 54.4 billion—
FY2024Consolidated · Filed Mar 19, 2025KRW 34 billion-KRW 2.7 billion-KRW 1.6 billion—
  • Q3 2026 is computed as 9M 2026 minus H1 2026.
  • Q2 2026 is computed as H1 2026 minus Q1 2026.
  • Q4 2025 is computed as FY2025 minus 9M 2025.
  • Q3 2025 is computed as 9M 2025 minus H1 2025.
  • Q2 2025 is computed as H1 2025 minus Q1 2025.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
8.33%
Of trading value on Nov 13, 2026
Short-sale value
KRW 620 million
Previous 20-day average 7.96%
Net short position
296,548 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
3,210,901 shares
As of Nov 13, 2026 · 8.39% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 20268.33%KRW 620 million
Nov 12, 20267.53%KRW 380 million
Nov 11, 20264.48%KRW 260 million
Nov 10, 20269.16%KRW 520 million
Nov 9, 202610.14%KRW 600 million
Nov 6, 20268.30%KRW 830 million
Nov 5, 20265.54%KRW 630 million
Nov 4, 202613.87%KRW 1.02 billion
Nov 3, 20269.37%KRW 490 million
Nov 2, 202611.99%KRW 460 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

Oscotec (039200) stock information

KOSDAQ

Oscotec (039200) is listed on KOSDAQ. Its market capitalization is about KRW 1.3 trillion. On trailing-twelve-month earnings the P/E ratio is 17.4, and the P/B ratio is 6.77. Return on equity is 38.9%. These figures are computed in-house from official filings and are reference information only.

Oscotec — frequently asked questions

What is the P/E ratio of Oscotec (039200)?
On a trailing-twelve-month basis, 039200 trades at a P/E ratio of 17.4. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Oscotec?
039200 has a market capitalization of about KRW 1.3 trillion. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.